GSK (CHIX:GSKL) FFO


CHIX:GSKL GSK PLC CHIX:GSKL
82 GF Score
Price £19.78
GF Value £16.47
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is GSK FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:GSKL
82GF Score
GSK PLC CHIX:GSKL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GSK (CHIX:GSKL) Overvalued in 2026?

Based on GuruFocus' analysis, GSK stock appears to be overvalued. The current stock price of £19.78 is trading 20.1% above its estimated GF Value™ of £16.47. GuruFocus considers GSK to be Modestly Overvalued.

Key valuation signals for CHIX:GSKL:

  • FFO:
  • GF Value™: £16.47 vs. price of £19.78 (20.1% above fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the CHIX:GSKL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GSK Business Description

Address 79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
82GF Score

Get the complete analysis for CHIX:GSKL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£19.78
Price
£16.47
GF Value